FABIflu 200 mg / 400 mg Tablets: Product Information, Uses, Benefits and Side Effects

FABIflu 200 mg and 400 mg tablets are pharmaceutical products associated with favipiravir, an antiviral medicine. Favipiravir acts by interfering with viral RNA replication. However, its suitability and effectiveness depend on the specific viral infection, clinical evidence and applicable treatment guidelines.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information for healthcare professionals, distributors and international pharmaceutical buyers. Before considering FABIflu for the Singapore market, verify the product's actual manufacturer, composition, approved indications, packaging and regulatory status.

FABIflu Tablets: Composition and Strengths

FABIflu is commonly associated with the following tablet strengths:

FABIflu 200 mg Tablets: A 200 mg strength presentation.

FABIflu 400 mg Tablets: A 400 mg strength presentation.

These strengths refer to the commonly listed favipiravir formulations. Confirm the composition and strength against the specific product label before publication or procurement.

Potential Benefits and Uses of Favipiravir

Favipiravir is an antiviral agent that targets viral RNA-dependent RNA polymerase, an enzyme involved in viral replication. Its potential clinical role depends on the virus being treated and supporting clinical evidence.

Potential areas of medical interest include:

Antiviral research: Studied for activity against certain RNA viruses.

Clinical evaluation: Investigated for selected viral infections in different countries.

Treatment planning: May be considered only where supported by applicable product approvals and professional medical guidance.

These points do not establish that FABIflu is approved or recommended for treating any particular infection in Singapore. Patients should not use it to treat COVID-19, influenza or another viral illness without advice from a qualified healthcare professional.

FABIflu Side Effects and Safety Precautions

Favipiravir may cause adverse effects, and its safety profile depends on the patient and treatment circumstances. Reported or recognised concerns can include nausea, diarrhoea, vomiting and elevated uric acid levels.

Important precautions include:

Pregnancy: Favipiravir carries significant embryo-fetal risk and must not be used during pregnancy.

Liver health: Medical assessment and appropriate monitoring may be necessary.

Drug interactions: Inform your doctor about all medicines and supplements you take.

Medical supervision: Follow the approved product information and prescribed instructions.

Seek medical attention if you experience a severe or unexpected reaction. Do not self-medicate or change a prescribed treatment without consulting your healthcare professional.

Frequently Asked Questions About FABIflu

1. What is FABIflu 200 mg used for?

Its intended use depends on the verified active ingredient and locally approved product information. Consult a healthcare professional before use.

2. What is the difference between FABIflu 200 mg and 400 mg?

The strengths contain different stated amounts per tablet. They are not interchangeable on a tablet-for-tablet basis without professional dosing guidance.

3. Can I buy FABIflu tablets in Singapore?

Availability depends on the product's regulatory status and lawful supply arrangements. Check the Singapore Health Sciences Authority (HSA) register before purchasing or importing.

4. What are the common side effects of favipiravir?

Possible adverse effects include gastrointestinal symptoms and increased uric acid. Consult the product leaflet for the complete safety information.

5. How can pharmaceutical buyers enquire about FABIflu?

Healthcare distributors and pharmaceutical buyers can contact Cordium Pharmaceuticals Pvt Ltd to request verified product specifications, manufacturing details and applicable export documentation.

Contact Cordium Pharmaceuticals Pvt Ltd

For product enquiries, pharmaceutical sourcing or international distribution discussions, contact Cordium Pharmaceuticals Pvt Ltd through its verified official business channels. Product supply to Singapore must comply with applicable HSA registration, import and advertising requirements.

Medical disclaimer: This content is for general product information and is not a substitute for medical advice. Product claims must be supported by verified documentation and applicable regulatory approvals.